Oncternal Therapeutics Presents Updated Interim Data for TK216 in Patients with Relapsed or Refractory Ewing Sarcoma in an Oral Session at ASCO 2021

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access